Oxybutynin Chloride Extended-release Tablets 5 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

CompletedNCT00650481

Mylan Pharmaceuticals IncHealthy

Start: 2002-12-31End: 2003-01-31Updated: 2024-04-24

Food Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg

CompletedNCT00648843

Mylan Pharmaceuticals IncHealthy

Start: 2002-12-31End: 2003-01-31Updated: 2024-04-24